Fábio Antonio Serra de Lima Junior

Fábio Antonio Serra de Lima Junior

Auto-generated profile, based on publicly available information

Fábio Antonio Serra de Lima Junior

Centro de Ciências Médicas, Universidade Federal da Paraíba (Federal University of Paraíba), João Pessoa, Castelo Branco, PB , 58051-900

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in Epidemiologic Reviews
Verified
Journal Article
Closed access
SPShelly Melissa Pranić
Shelly Melissa Pranić
M. Dulce EstêvãoM. Dulce Estêvão
M. Dulce Estêvão
LVLenny T Vasanthan
Lenny T Vasanthan
IPIván Pérez-Neri
Iván Pérez-Neri
APAnika Pulumati
Anika Pulumati
Daniel A. NnateDaniel A. Nnate
Daniel A. Nnate
Racial and ethnic minorities have been disproportionally burdened by hospitalization and death due to COVID-19. Participation of individuals of diverse races and ethnicities in clinical trials, according to study-level characteristics of randomized controlled trials (RCTs) that test effectiveness of COVID-19 drugs, could be insightful for future researchers. Our objective for this scoping review was to describe the frequency of race and ethnicity reported as demographic variables and specific reporting of race and ethnicity according to COVID-19 RCT characteristics. We conducted comprehensive searches in PubMed, ProQuest, World Health Organization Database, and Cochrane Central Register of Controlled Trials, and gray literature via preprint servers from January 1, 2020, to May 4, 2022. We included RCTs on emergency- or conditionally approved COVID-19 drug interventions (remdesivir, baricitinib, and molnupiravir) with or without comparators. Self-reported race as American Indian/Pacific Islander, Asian, Black/African American, or White, ethnicity as Hispanic/Latinx, study design characteristics, and participant-relevant data were collected. In total, 17 RCTs with 17 935 participants were included. Most (n = 13; 76%) reported at least 1 race and ethnicity and were US-based, industry-funded RCTs. Asian, Black, Latinx, and White participants were mostly enrolled in RCTs that studied remdesivir. Native American and Hawaiian participants were mostly assessed for progression to high-flow oxygen/noninvasive ventilation. Time to recovery was assessed predominantly in Black and White participants, whereas hospitalization or death was mostly assessed in Asian, Latinx, and multirace participants. Trialists should be aware of RCT-level factors and characteristics that may be associated with low participation of racial and ethnic minorities, which could inform evidence-based interventions to increase minority participation.

27 November 2023 in Medicina (Ribeirão Preto)
Verified
Journal Article
Open access
PSPedro Henrique Borges Sousa
Pedro Henrique Borges Sousa
HTHugo Alexandre Sousa Targino
Hugo Alexandre Sousa Targino
FJFábio Antônio Serra de Lima Júnior
Fábio Antônio Serra de Lima Júnior
CCCamila Melo de Oliveira Costa
Camila Melo de Oliveira Costa
TSThiago Lins Fagundes de Sousa
Thiago Lins Fagundes de Sousa
IBIjanileide Gabriel de Araújo Braga
Ijanileide Gabriel de Araújo Braga
Objetivo: Avaliar o padrão de espirometria de pacientes que persistiram com sintomas respiratórios após a infecção pelo SARS-CoV-2. Métodos: Estudo transversal, observacional e retrospectivo realizado em um único centro, aprovado pelo Comitê de Ética local (número do parecer: 5.120.720). Foram avaliados pacientes submetidos a espirometria devido à Síndrome Pós-Covid, a fim de analisar o padrão espirométrico apresentado. Os seguintes dados foram coletados: identificação do exame, sexo, idade, tempo de sintomas, necessidade de ventilação mecânica, qualidade da espirometria, além dos seguintes parâmetros do exame: CVF, VEF1, VEF1/CVF, VEF 25-75/CVF e VEF 75, avaliando o Limite Inferior da Normalidade, valores pré-broncodilatador e pós-broncodilatador. Resultados: Foram coletados dados de 72 pacientes. Destes, 55,5% apresentaram resultados espirométricos dentro dos limites normais. A alteração respiratória mais frequente foi o distúrbio ventilatório obstrutivo, presente em 29,2% dos pacientes. Conclusões: A presença de dispneia em pacientes com espirometria dentro da normalidade pode indicar uma avaliação adicional da função pulmonar, assim como outras etiologias para a dispneia.

24 October 2022 in International Journal of Health Science
Verified
Journal Article
Open access
MFMariana Moreira de Oliveira Fama
Mariana Moreira de Oliveira Fama
ABAna Beatriz Venâncio de Paula Bezerra
Ana Beatriz Venâncio de Paula Bezerra
AAAna Vitória Borges de Amorim
Ana Vitória Borges de Amorim
BGBruna Guimarães
Bruna Guimarães
FJFábio Antônio Serra de Lima Júnior
Fábio Antônio Serra de Lima Júnior
SMShirlane Frutuoso Malheiros
Shirlane Frutuoso Malheiros
Introduction : Crohn's disease (CD) has a median age at diagnosis of 29.5 years and only 5% of cases are diagnosed from intestinal strictures. These are less frequent than fistulas and, when they do occur, are more frequent in the ileum and less frequently in the colon. Case report: A 50-year-old male patient complained of progressive constipation, anal pain, increased defecation effort and hematochezia. During an outpatient investigation, in 2016, he underwent colonoscopy, which showed low rectal stenosis, insurmountable by the device. In a new attempt at colonoscopy in 2017, additional ulcerated lesions were described at the anal margin associated with stenosing fibrosis that prevented the device from progressing, marking the beginning of suspected anorectal tumor. However, the anatomopathological examination showed no signs of malignancy. With the worsening of the symptoms, he was referred to Coloproctology in 2019, due to the suspicion of neoplasia. Examination under narcosis was indicated for anal dilatation and collection of anatomopathological material. The new anatomopathological examination showed that the elevated lesion was a fibroepithelial polyp, while the examination of the rectal mucosa showed an intense chronic inflammatory process with fibrosis and crypt microabscesses suggestive of IBD. Discussion: Although IBDs can occur at any age, CD is usually diagnosed between the ages of 15 and 35. It is also noteworthy that the main symptoms of Crohn's disease are diarrhea, abdominal pain and weight loss, with stenosis being the cause of diagnosis in only 5% of cases. Faced with advanced age, changes in bowel habits, obstructive symptoms and weight loss, the differential diagnosis with anorectal neoplasia is essential. Conclusion: The diagnosis of stenosing IBDs must be kept in mind as a differential in the face of obstructive symptoms, even in patients with epidemiology and clinics compatible with neoplasia, to avoid delaying treatment and its complications.

14 March 2024 in Research Square
Verified
Preprint
Open access
PDF file
SPShelly Melissa Pranić
Shelly Melissa Pranić
M. Dulce EstêvãoM. Dulce Estêvão
M. Dulce Estêvão
LVLenny T. Vasanthan
Lenny T. Vasanthan
IPIván Pérez-Neri
Iván Pérez-Neri
APAnika Pulumati
Anika Pulumati
DNDaniel Nnate
Daniel Nnate
Racial and ethnic minorities have been disproportionally burdened by hospitalization and death due to COVID-19. Participation of individuals of diverse races and ethnicities in clinical trials according to study-level characteristics of randomized controlled trials (RCT) that test effectiveness of COVID-19 drugs could be insightful for future researchers. The objective of this scoping review was to describe frequency of race and ethnicity reported as demographic variables and specific reporting of race and ethnicity according to COVID-19 RCT characteristics. We conducted comprehensive searches in Pubmed, ProQuest, WHO Database, and Cochrane Central Register of Controlled Trials, and gray literature via preprint servers from 1/1/2020 to 5/4/2022. We included RCTs on emergency- or conditionally-approved COVID-19 drug interventions (remdesivir, barcitinib, and molnupiravir) with or without comparators. Self-reported race as American Indian/Pacific Islander, Asian, Black/African American, or White, ethnicity as Hispanic/Latinx, study design characteristics, and participant-relevant data were collected. A total of 17 RCTs with 17935 participants was included. Most (n=13, 76%) reported at least one race and ethnicity and were US-based, industry-funded RCTs. Asian, Black, Latinx, and White participants were mostly enrolled in RCTs that studied remdesivir. Native American and Hawaiian participants were mostly assessed for progression to high-flow oxygen/non-invasive ventilation. Time to recovery was assessed predominantly in Black and White participants, while hospitalization or death was mostly assessed in Asian, Latinx, and multi-race participants. Trialists should be aware of RCT-level factors and characteristics that may be associated with low participation of racial and ethnic minorities, which could inform evidence-based interventions to increase minority participation. Registration: Open Science Framework: https://osf.io/3dx4f/?view_only=d1af00d952cc472b803df5297bce9a80

5 April 2024 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
JRJosé Vitor Alécio Rodrigues
José Vitor Alécio Rodrigues
FLFábio Antônio Serra de Lima
Fábio Antônio Serra de Lima
DBDaniel Pereira Maurício de Barros
Daniel Pereira Maurício de Barros
GFGustavo Leite Franklin
Gustavo Leite Franklin
ANAdriana Meira Tiburtino Nepomuceno
Adriana Meira Tiburtino Nepomuceno
AMAlex T. Meira
Alex T. Meira
Henrik and Torsten Sjögren (/ˈʃoʊɡrən/ or SHOH–grən) were two Swedish physicians living in the same period, but completely unrelated, except for their notable contributions to Medicine. The first one described keratoconjunctivitis sicca, afterward called Sjögren's syndrome, and a fishing net aspect retinal pigmentation affecting visual acuity, nowadays known as Sjögren reticular dystrophy. The last one contributed to the understanding of Spielmeyer-Sjögren disease, Marinesco-Sjögren, and Sjögren-Larsson syndromes, all related to genetic disorders and neurological symptoms. In this paper, we aim to describe each disorder, in order to avoid any misunderstanding in diagnosis and for historical record.

2 September 2022 in Radiology Case Reports
Verified
Journal Article
Open access
VAVictor Oliveira Araújo
Victor Oliveira Araújo
PMPaulo Filho Soares Marcelino
Paulo Filho Soares Marcelino
SRSamuel Ramos Rabelo
Samuel Ramos Rabelo
FJFabio Antonio Serra de Lima Junior
Fabio Antonio Serra de Lima Junior
VTVitor Gil Gonçalves Teixeira
Vitor Gil Gonçalves Teixeira
EJEuldes Mendes Júnior
Euldes Mendes Júnior
The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurologic exam showed complete and proportionate left hemiparesis with pyramidal signs and clonus, loss of proprioception and vibration in lower limbs, tactile, and painful hypoesthesia on the left side. This report describes a rare case of Marburg variant associated with COVID-19 infection.